)
Corbus Pharmaceuticals (CRBP) investor relations material
Corbus Pharmaceuticals Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for May 13, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and annual report before voting.
Voting matters and shareholder proposals
Election of six directors: Yuval Cohen, Rachelle Jacques, Winston Kung, John Jenkins, Anne Altmeyer, and Yong Ben.
Proposal to amend the 2024 Equity Compensation Plan, increasing authorized shares by 3,000,000 to a total of 5,000,000.
Ratification of EisnerAmper LLP as independent auditor for the year ending December 31, 2026.
Advisory vote on executive compensation for named executive officers.
Advisory vote on the frequency of future say-on-pay votes, with a recommendation for annual votes.
Board of directors and corporate governance
Six nominees presented for election to the board, reflecting ongoing governance and oversight.
- Board seeks approval for director elections, equity plan amendment, and annual say-on-pay votes.CRBP
Proxy filing2 Apr 2026 - CRB-701 and CRB-913 show promising efficacy and safety, with pivotal data expected in 2026.CRBP
Corporate presentation23 Mar 2026 - Shelf registration allows up to $300M in flexible offerings to advance oncology and obesity programs.CRBP
Registration Filing11 Mar 2026 - CRB-701 and CRB-913 show strong clinical promise, with pivotal data expected in 2026.CRBP
Corporate presentation9 Mar 2026 - Strong clinical progress and financing position support continued development into 2028.CRBP
Q4 20259 Mar 2026 - Transformative clinical data for oncology and obesity assets expected in 2024.CRBP
Oppenheimer 36th Annual Healthcare Life Sciences Conference25 Feb 2026 - Pivotal 2026 data expected for lead oncology and obesity programs, with strong early results.CRBP
Corporate presentation25 Feb 2026 - Advancing oncology and obesity programs with strong cash position and key data expected in 2024-2025.CRBP
Goldman Sachs 45th Annual Global Healthcare Conference3 Feb 2026 - CB-1 and Nectin-4 ADC programs advance with promising safety, efficacy, and key data expected soon.CRBP
2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
Next Corbus Pharmaceuticals earnings date
Next Corbus Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage